Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation | Zendy

Tamara Brown | Zendy; Gerlinde Pilkington | Zendy; A Bagust | Zendy; Angela Boland | Zendy; J Oyee | Zendy; Catrin Tudur Smith | Zendy; M Blundell | Zendy; MeiShu Lai | Zendy; C Martin Saborido | Zendy; J Greenhalgh | Zendy; Y Dündar | Zendy; Rumona Dickson | Zendy

Open Access

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Author(s) -

Tamara Brown,

Gerlinde Pilkington,

A Bagust,

Angela Boland,

J Oyee,

Catrin Tudur Smith,

M Blundell,

MeiShu Lai,

C Martin Saborido,

J Greenhalgh,

Y Dündar,

Rumona Dickson

Publication year - 2013

Publication title -

health technology assessment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.426

H-Index - 126

eISSN - 2046-4924

pISSN - 1366-5278

DOI - 10.3310/hta17310

Subject(s) - medicine , cost effectiveness , intensive care medicine , economic evaluation , lung cancer , chemotherapy , cancer , oncology , health technology , medical physics , health care , risk analysis (engineering) , pathology , economics , economic growth

The National Institute for Health and Care Excellence (NICE) has issued multiple guidance for the first-line management of patients with lung cancer and recommends different combinations of chemotherapy treatments. This review provides a synthesis of clinical effectiveness and cost-effectiveness evidence supporting current guidance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research